Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roles of Del-1 in effects of hyponatremia on muscle and bone in mice.

Bone·2026
Same author

Systemic administration of osteoblast-derived collagenase released extracellular vesicles restores trabecular bone loss in ovariectomized mice.

Bone·2026
Same author

Tmem119 is involved in the bone repair enhanced by parathyroid hormone in female mice.

The Journal of endocrinology·2026
Same author

Visually Appealing iEat® Food Products Enhance Visual Cortex Activity in Patients with Dysphagia: A Functional MRI (fMRI) Study.

Cureus·2025
Same author

The role of Tmem119 in the estrogen action on bone in mice.

Journal of bone and mineral metabolism·2025
Same author

Goal-setting improves movement accuracy during unsupervised training in stroke patients.

Scientific reports·2025

Related Experiment Videos

Mild renal dysfunction is a risk factor for a decrease in bone mineral density and vertebral fractures in Japanese

Hiroshi Kaji1, Mika Yamauchi, Toru Yamaguchi

  • 1Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Chuo-ku, Kobe, Japan. hiroshik@med.kobe-u.ac.jp

The Journal of Clinical Endocrinology and Metabolism
|July 16, 2010
PubMed
Summary

Mild renal dysfunction increases the risk of decreased bone mineral density (BMD) and vertebral fractures (VFs) in postmenopausal women. This study highlights the importance of monitoring kidney function in this population.

Related Experiment Videos

Area of Science:

  • Nephrology
  • Endocrinology
  • Geriatrics

Background:

  • The relationship between mild renal dysfunction and bone health, specifically bone mineral density (BMD) and fracture risk, remains unclear.
  • Postmenopausal women are particularly susceptible to bone loss and fractures.

Purpose of the Study:

  • To investigate the impact of mild renal dysfunction on BMD and the risk of vertebral fractures (VFs) in postmenopausal women.
  • To identify specific markers of renal function associated with bone health outcomes.

Main Methods:

  • Calculated creatinine clearance (CCr) and estimated glomerular filtration rate (eGFR) using established formulas.
  • Measured BMD via dual-energy x-ray absorptiometry.
  • Classified renal function according to Kidney Disease Outcomes Quality Initiative Committee criteria.

Main Results:

  • A significantly higher prevalence of VFs was observed in women with eGFR stage 3 or greater (45.3%) compared to stages 1 (23.8%) and 2 (25.3%).
  • In stage 2 chronic kidney disease, positive correlations were found between eGFR/CCr and BMD at multiple sites.
  • Lower eGFR and CCr levels were associated with the presence of VFs in stage 2 postmenopausal women.

Conclusions:

  • Mild renal dysfunction is associated with an increased risk of decreased BMD and VFs in postmenopausal women.
  • Renal function, particularly CCr, is a significant factor associated with VFs in postmenopausal women with stage 2 chronic kidney disease.